Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 238 entries
Sorted by: Best Match Show Resources per page
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release.

Psychopharmacology

Martinotti G, Barlati S, Prestia D, Palumbo C, Giordani M, Cuomo A, Miuli A, Paladini C, Amore M, Bondi E, Vita A, Fagiolini A, Di Giannantonio M.
PMID: 32821983
Psychopharmacology (Berl). 2020 Nov;237(11):3497-3501. doi: 10.1007/s00213-020-05644-3. Epub 2020 Aug 21.

No abstract available.

Cite
Martinotti G, Barlati S, Prestia D, et al. Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release. Psychopharmacology (Berl). 2020;237(11):3497-3501doi: 10.1007/s00213-020-05644-3.
Martinotti, G., Barlati, S., Prestia, D., Palumbo, C., Giordani, M., Cuomo, A., Miuli, A., Paladini, C., Amore, M., Bondi, E., Vita, A., Fagiolini, A., & Di Giannantonio, M. (2020). Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release. Psychopharmacology, 237(11), 3497-3501. https://doi.org/10.1007/s00213-020-05644-3
Martinotti, Giovanni, et al. "Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release." Psychopharmacology vol. 237,11 (2020): 3497-3501. doi: https://doi.org/10.1007/s00213-020-05644-3
Martinotti G, Barlati S, Prestia D, Palumbo C, Giordani M, Cuomo A, Miuli A, Paladini C, Amore M, Bondi E, Vita A, Fagiolini A, Di Giannantonio M. Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release. Psychopharmacology (Berl). 2020 Nov;237(11):3497-3501. doi: 10.1007/s00213-020-05644-3. Epub 2020 Aug 21. PMID: 32821983; PMCID: PMC7441014.
Copy Download .nbib Format: NLM
Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats.

Psychopharmacology

Ruiz CM, Torrens A, Lallai V, Castillo E, Manca L, Martinez MX, Justeson DN, Fowler CD, Piomelli D, Mahler SV.
PMID: 34495367
Psychopharmacology (Berl). 2021 Dec;238(12):3595-3605. doi: 10.1007/s00213-021-05976-8. Epub 2021 Sep 08.

RATIONALE: Adolescent exposure to ∆OBJECTIVES: We investigated the pharmacokinetics and pharmacodynamics of aerosolized THC (30 min inhalation exposure, 25 or 100 mg/ml) in adolescent Wistar rats of both sexes.METHODS: Liquid chromatography/mass spectrometry analysis of THC and its major metabolites...

Cite
Ruiz CM, Torrens A, Lallai V, et al. Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats. Psychopharmacology (Berl). 2021;238(12):3595-3605doi: 10.1007/s00213-021-05976-8.
Ruiz, C. M., Torrens, A., Lallai, V., Castillo, E., Manca, L., Martinez, M. X., Justeson, D. N., Fowler, C. D., Piomelli, D., & Mahler, S. V. (2021). Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats. Psychopharmacology, 238(12), 3595-3605. https://doi.org/10.1007/s00213-021-05976-8
Ruiz, C M, et al. "Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats." Psychopharmacology vol. 238,12 (2021): 3595-3605. doi: https://doi.org/10.1007/s00213-021-05976-8
Ruiz CM, Torrens A, Lallai V, Castillo E, Manca L, Martinez MX, Justeson DN, Fowler CD, Piomelli D, Mahler SV. Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats. Psychopharmacology (Berl). 2021 Dec;238(12):3595-3605. doi: 10.1007/s00213-021-05976-8. Epub 2021 Sep 08. PMID: 34495367.
Copy Download .nbib Format: NLM
Correction to: Propofol but not dexmedetomidine produce locomotor sensitization via nitric oxide in rats.

Psychopharmacology

Uskur T, Şenöz AÖ, Çevreli B, Barlas A, Uzbay T.
PMID: 33216168
Psychopharmacology (Berl). 2021 Feb;238(2):579. doi: 10.1007/s00213-020-05724-4.

No abstract available.

Cite
Uskur T, Şenöz AÖ, Çevreli B, et al. Correction to: Propofol but not dexmedetomidine produce locomotor sensitization via nitric oxide in rats. Psychopharmacology (Berl). 2021;238(2):579doi: 10.1007/s00213-020-05724-4.
Uskur, T., Şenöz, A. �. �., Çevreli, B., Barlas, A., & Uzbay, T. (2021). Correction to: Propofol but not dexmedetomidine produce locomotor sensitization via nitric oxide in rats. Psychopharmacology, 238(2), 579. https://doi.org/10.1007/s00213-020-05724-4
Uskur, Tuğçe, et al. "Correction to: Propofol but not dexmedetomidine produce locomotor sensitization via nitric oxide in rats." Psychopharmacology vol. 238,2 (2021): 579. doi: https://doi.org/10.1007/s00213-020-05724-4
Uskur T, Şenöz AÖ, Çevreli B, Barlas A, Uzbay T. Correction to: Propofol but not dexmedetomidine produce locomotor sensitization via nitric oxide in rats. Psychopharmacology (Berl). 2021 Feb;238(2):579. doi: 10.1007/s00213-020-05724-4. PMID: 33216168.
Copy Download .nbib Format: NLM
Early environmental enrichment and impoverishment differentially affect addiction-related behavioral traits, cocaine-taking, and dopamine D.

Psychopharmacology

Bellés L, Dimiziani A, Herrmann FR, Ginovart N.
PMID: 34463825
Psychopharmacology (Berl). 2021 Dec;238(12):3543-3557. doi: 10.1007/s00213-021-05971-z. Epub 2021 Aug 31.

RATIONALE: Risk factors for drug addiction include genetics, environment, and behavioral traits such as impulsivity and novelty preference (NP), which have been related to deficits in striatal dopamine (DA) DOBJECTIVES: We investigated the influence of early rearing environment on...

Cite
Bellés L, Dimiziani A, Herrmann FR, et al. Early environmental enrichment and impoverishment differentially affect addiction-related behavioral traits, cocaine-taking, and dopamine D. Psychopharmacology (Berl). 2021;238(12):3543-3557doi: 10.1007/s00213-021-05971-z.
Bellés, L., Dimiziani, A., Herrmann, F. R., & Ginovart, N. (2021). Early environmental enrichment and impoverishment differentially affect addiction-related behavioral traits, cocaine-taking, and dopamine D. Psychopharmacology, 238(12), 3543-3557. https://doi.org/10.1007/s00213-021-05971-z
Bellés, Lidia, et al. "Early environmental enrichment and impoverishment differentially affect addiction-related behavioral traits, cocaine-taking, and dopamine D." Psychopharmacology vol. 238,12 (2021): 3543-3557. doi: https://doi.org/10.1007/s00213-021-05971-z
Bellés L, Dimiziani A, Herrmann FR, Ginovart N. Early environmental enrichment and impoverishment differentially affect addiction-related behavioral traits, cocaine-taking, and dopamine D. Psychopharmacology (Berl). 2021 Dec;238(12):3543-3557. doi: 10.1007/s00213-021-05971-z. Epub 2021 Aug 31. PMID: 34463825.
Copy Download .nbib Format: NLM
Sucrose intake by rats affected by both intraperitoneal oxytocin administration and time of day.

Psychopharmacology

Rehn S, Raymond JS, Boakes RA, Bowen MT.
PMID: 34731267
Psychopharmacology (Berl). 2021 Nov 03; doi: 10.1007/s00213-021-06014-3. Epub 2021 Nov 03.

RATIONALE: Daily limited access to palatable food or drink at a fixed time is commonly used in rodent models of bingeing. Under these conditions, entrainment may modulate intake patterns. Oxytocin is involved in circadian patterns of intake and, when...

Cite
Rehn S, Raymond JS, Boakes RA, et al. Sucrose intake by rats affected by both intraperitoneal oxytocin administration and time of day. Psychopharmacology (Berl). 2021;doi: 10.1007/s00213-021-06014-3.
Rehn, S., Raymond, J. S., Boakes, R. A., & Bowen, M. T. (2021). Sucrose intake by rats affected by both intraperitoneal oxytocin administration and time of day. Psychopharmacology, . https://doi.org/10.1007/s00213-021-06014-3
Rehn, Simone, et al. "Sucrose intake by rats affected by both intraperitoneal oxytocin administration and time of day." Psychopharmacology vol. (2021). doi: https://doi.org/10.1007/s00213-021-06014-3
Rehn S, Raymond JS, Boakes RA, Bowen MT. Sucrose intake by rats affected by both intraperitoneal oxytocin administration and time of day. Psychopharmacology (Berl). 2021 Nov 03; doi: 10.1007/s00213-021-06014-3. Epub 2021 Nov 03. PMID: 34731267.
Copy Download .nbib Format: NLM
The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia.

Psychopharmacology

Lang X, Liu Q, Fang H, Zhou Y, Forster MT, Li Z, Zhang X.
PMID: 34586464
Psychopharmacology (Berl). 2021 Dec;238(12):3643-3652. doi: 10.1007/s00213-021-05983-9. Epub 2021 Sep 29.

RATIONALE: Although metabolic abnormalities and metabolic syndrome (MetS) have been extensively investigated in schizophrenia, few studies have examined them in first-episode drug-naive (FEDN) patients.OBJECTIVES: This study aimed to investigate the prevalence and clinical correlates of metabolic abnormalities in FEDN...

Cite
Lang X, Liu Q, Fang H, et al. The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia. Psychopharmacology (Berl). 2021;238(12):3643-3652doi: 10.1007/s00213-021-05983-9.
Lang, X., Liu, Q., Fang, H., Zhou, Y., Forster, M. T., Li, Z., & Zhang, X. (2021). The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia. Psychopharmacology, 238(12), 3643-3652. https://doi.org/10.1007/s00213-021-05983-9
Lang, Xiaoe, et al. "The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia." Psychopharmacology vol. 238,12 (2021): 3643-3652. doi: https://doi.org/10.1007/s00213-021-05983-9
Lang X, Liu Q, Fang H, Zhou Y, Forster MT, Li Z, Zhang X. The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia. Psychopharmacology (Berl). 2021 Dec;238(12):3643-3652. doi: 10.1007/s00213-021-05983-9. Epub 2021 Sep 29. PMID: 34586464.
Copy Download .nbib Format: NLM
Correction to: Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls.

Psychopharmacology

Hermans LWA, Regis M, Fonseca P, Overeem S, Leufkens TRM, Vermeeren A, van Gilst MM.
PMID: 33118053
Psychopharmacology (Berl). 2021 Jan;238(1):95. doi: 10.1007/s00213-020-05675-w.

No abstract available.

Cite
Hermans LWA, Regis M, Fonseca P, et al. Correction to: Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls. Psychopharmacology (Berl). 2021;238(1):95doi: 10.1007/s00213-020-05675-w.
Hermans, L. W. A., Regis, M., Fonseca, P., Overeem, S., Leufkens, T. R. M., Vermeeren, A., & van Gilst, M. M. (2021). Correction to: Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls. Psychopharmacology, 238(1), 95. https://doi.org/10.1007/s00213-020-05675-w
Hermans, Lieke W A, et al. "Correction to: Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls." Psychopharmacology vol. 238,1 (2021): 95. doi: https://doi.org/10.1007/s00213-020-05675-w
Hermans LWA, Regis M, Fonseca P, Overeem S, Leufkens TRM, Vermeeren A, van Gilst MM. Correction to: Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls. Psychopharmacology (Berl). 2021 Jan;238(1):95. doi: 10.1007/s00213-020-05675-w. PMID: 33118053; PMCID: PMC7852977.
Copy Download .nbib Format: NLM
Correction to: Inhibition of a cortico-thalamic circuit attenuates cue-induced reinstatement of drug-seeking behavior in "relapse prone" male rats.

Psychopharmacology

Kuhn BN, Campus P, Klumpner MS, Chang SE, Iglesias AG, Flagel SB.
PMID: 34286346
Psychopharmacology (Berl). 2021 Jul 21; doi: 10.1007/s00213-021-05919-3. Epub 2021 Jul 21.

No abstract available.

Cite
Kuhn BN, Campus P, Klumpner MS, et al. Correction to: Inhibition of a cortico-thalamic circuit attenuates cue-induced reinstatement of drug-seeking behavior in "relapse prone" male rats. Psychopharmacology (Berl). 2021;doi: 10.1007/s00213-021-05919-3.
Kuhn, B. N., Campus, P., Klumpner, M. S., Chang, S. E., Iglesias, A. G., & Flagel, S. B. (2021). Correction to: Inhibition of a cortico-thalamic circuit attenuates cue-induced reinstatement of drug-seeking behavior in "relapse prone" male rats. Psychopharmacology, . https://doi.org/10.1007/s00213-021-05919-3
Kuhn, Brittany N, et al. "Correction to: Inhibition of a cortico-thalamic circuit attenuates cue-induced reinstatement of drug-seeking behavior in "relapse prone" male rats." Psychopharmacology vol. (2021). doi: https://doi.org/10.1007/s00213-021-05919-3
Kuhn BN, Campus P, Klumpner MS, Chang SE, Iglesias AG, Flagel SB. Correction to: Inhibition of a cortico-thalamic circuit attenuates cue-induced reinstatement of drug-seeking behavior in "relapse prone" male rats. Psychopharmacology (Berl). 2021 Jul 21; doi: 10.1007/s00213-021-05919-3. Epub 2021 Jul 21. PMID: 34286346.
Copy Download .nbib Format: NLM
Paeonol triggers apoptosis in HeLa cervical cancer cells: the role of mitochondria-related caspase pathway.

Psychopharmacology

Du J, Song D, Li J, Li Y, Li B, Li L.
PMID: 33710373
Psychopharmacology (Berl). 2021 Mar 12; doi: 10.1007/s00213-021-05811-0. Epub 2021 Mar 12.

Paeonol is a biologically active component purified from the root bark of Cortex Moutan that exerts pharmacological effects on the cervical cancer. In this study, we aim to evaluate the anti-cervical cancer capacity of paeonol and to investigate the...

Cite
Du J, Song D, Li J, et al. Paeonol triggers apoptosis in HeLa cervical cancer cells: the role of mitochondria-related caspase pathway. Psychopharmacology (Berl). 2021;doi: 10.1007/s00213-021-05811-0.
Du, J., Song, D., Li, J., Li, Y., Li, B., & Li, L. (2021). Paeonol triggers apoptosis in HeLa cervical cancer cells: the role of mitochondria-related caspase pathway. Psychopharmacology, . https://doi.org/10.1007/s00213-021-05811-0
Du, Jikun, et al. "Paeonol triggers apoptosis in HeLa cervical cancer cells: the role of mitochondria-related caspase pathway." Psychopharmacology vol. (2021). doi: https://doi.org/10.1007/s00213-021-05811-0
Du J, Song D, Li J, Li Y, Li B, Li L. Paeonol triggers apoptosis in HeLa cervical cancer cells: the role of mitochondria-related caspase pathway. Psychopharmacology (Berl). 2021 Mar 12; doi: 10.1007/s00213-021-05811-0. Epub 2021 Mar 12. PMID: 33710373.
Copy Download .nbib Format: NLM
Prospecting for a quinoline containing selenium for comorbidities depression and memory impairment induced by restriction stress in mice.

Psychopharmacology

de Oliveira RL, Voss GT, da C Rodrigues K, Pinz MP, Biondi JV, Becker NP, Blodorn E, Domingues WB, Larroza A, Campos VF, Alves D, Wilhelm EA, Luchese C.
PMID: 35013761
Psychopharmacology (Berl). 2022 Jan 11; doi: 10.1007/s00213-021-06039-8. Epub 2022 Jan 11.

RATIONALE: Depression is often associated with memory impairment, a clinical feature of Alzheimer's disease (AD), but no effective treatment is available. 7-Chloro-4-(phenylselanyl) quinoline (4-PSQ) has been studied in experimental models of diseases that affect the central nervous system.OBJECTIVES: The...

Cite
de Oliveira RL, Voss GT, da C Rodrigues K, et al. Prospecting for a quinoline containing selenium for comorbidities depression and memory impairment induced by restriction stress in mice. Psychopharmacology (Berl). 2022;doi: 10.1007/s00213-021-06039-8.
de Oliveira, R. L., Voss, G. T., da C Rodrigues, K., Pinz, M. P., Biondi, J. V., Becker, N. P., Blodorn, E., Domingues, W. B., Larroza, A., Campos, V. F., Alves, D., Wilhelm, E. A., & Luchese, C. (2022). Prospecting for a quinoline containing selenium for comorbidities depression and memory impairment induced by restriction stress in mice. Psychopharmacology, . https://doi.org/10.1007/s00213-021-06039-8
de Oliveira, Renata L, et al. "Prospecting for a quinoline containing selenium for comorbidities depression and memory impairment induced by restriction stress in mice." Psychopharmacology vol. (2022). doi: https://doi.org/10.1007/s00213-021-06039-8
de Oliveira RL, Voss GT, da C Rodrigues K, Pinz MP, Biondi JV, Becker NP, Blodorn E, Domingues WB, Larroza A, Campos VF, Alves D, Wilhelm EA, Luchese C. Prospecting for a quinoline containing selenium for comorbidities depression and memory impairment induced by restriction stress in mice. Psychopharmacology (Berl). 2022 Jan 11; doi: 10.1007/s00213-021-06039-8. Epub 2022 Jan 11. PMID: 35013761.
Copy Download .nbib Format: NLM
Professor Miloslav Krsiak 1939 - 2016.

Psychopharmacology

Sustkova-Fiserova M, Stolerman I.
PMID: 27761587
Psychopharmacology (Berl). 2017 Jan;234(1):1-2. doi: 10.1007/s00213-016-4465-9. Epub 2016 Oct 20.

No abstract available.

Cite
Sustkova-Fiserova M, Stolerman I. Professor Miloslav Krsiak 1939 - 2016. Psychopharmacology (Berl). 2016;234(1):1-2doi: 10.1007/s00213-016-4465-9.
Sustkova-Fiserova, M., & Stolerman, I. (2017). Professor Miloslav Krsiak 1939 - 2016. Psychopharmacology, 234(1), 1-2. https://doi.org/10.1007/s00213-016-4465-9
Sustkova-Fiserova, Magdalena, and Stolerman, Ian. "Professor Miloslav Krsiak 1939 - 2016." Psychopharmacology vol. 234,1 (2017): 1-2. doi: https://doi.org/10.1007/s00213-016-4465-9
Sustkova-Fiserova M, Stolerman I. Professor Miloslav Krsiak 1939 - 2016. Psychopharmacology (Berl). 2017 Jan;234(1):1-2. doi: 10.1007/s00213-016-4465-9. Epub 2016 Oct 20. PMID: 27761587.
Copy Download .nbib Format: NLM
The relationship between antidepressant treatment and inflammatory markers in early psychosis: preliminary results.

Psychopharmacology

Stojanovic-Pérez A, Martorell L, Montalvo I, Ortega L, Solé M, Moreno I, Vilella E, Labad J.
PMID: 27572626
Psychopharmacology (Berl). 2016 Oct;233(19):3659-61. doi: 10.1007/s00213-016-4413-8. Epub 2016 Aug 29.

No abstract available.

Cite
Stojanovic-Pérez A, Martorell L, Montalvo I, et al. The relationship between antidepressant treatment and inflammatory markers in early psychosis: preliminary results. Psychopharmacology (Berl). 2016;233(19):3659-61doi: 10.1007/s00213-016-4413-8.
Stojanovic-Pérez, A., Martorell, L., Montalvo, I., Ortega, L., Solé, M., Moreno, I., Vilella, E., & Labad, J. (2016). The relationship between antidepressant treatment and inflammatory markers in early psychosis: preliminary results. Psychopharmacology, 233(19), 3659-61. https://doi.org/10.1007/s00213-016-4413-8
Stojanovic-Pérez, Alexander, et al. "The relationship between antidepressant treatment and inflammatory markers in early psychosis: preliminary results." Psychopharmacology vol. 233,19 (2016): 3659-61. doi: https://doi.org/10.1007/s00213-016-4413-8
Stojanovic-Pérez A, Martorell L, Montalvo I, Ortega L, Solé M, Moreno I, Vilella E, Labad J. The relationship between antidepressant treatment and inflammatory markers in early psychosis: preliminary results. Psychopharmacology (Berl). 2016 Oct;233(19):3659-61. doi: 10.1007/s00213-016-4413-8. Epub 2016 Aug 29. PMID: 27572626.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 238 entries